Chemotherapy-induced peripheral neuropathy in immunodeficient mice: new useful ready-to-use animal models by Cavaletti, Guido et al.
IJAE 
Vo l .  118 ,  n .  2  (Supp lem ent) :  51,  2013
© 2013 Firenze University Press 
ht tp://www.fupress .com/ijae
ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY
Chemotherapy-induced peripheral neuropathy in immu-
nodeficient mice: new useful ready-to-use animal models
Guido Cavaletti, Valentina Carozzi, Alessia Chiorazzi, Norberto Oggioni, Virginia Rodriguez-
Menendez, Federica Avezza and Paola Marmiroli
Dipartimento di Chirurgia e Medicina Interdisciplinare, Scuola di Medicina, Università di Milano-Bicocca, Monza
Cisplatin, paclitaxel, and bortezomib represent the most employed chemothera-
py regimens for the treatment of genitourinary cancers, breast and lung cancers and 
multiple myeloma. Nevertheless, their clinical use is often associated to the develop-
ment of peripheral neuropathies characterized mostly by sensory alterations and pain 
(Argyriou et al., 2012). 
Several rat models of chemotherapy-induced peripheral neuropathy (CIPN) had 
been established in the past to describe the mechanisms of its development and 
pathogenesis. However, only few cancer cell lines induce the development of cancer 
in the rat, while immunodeficient mice best allowed human cancers xenografts to 
study at the same time, the antineoplastic and neurotoxic effects of chemotherapy.
Here we characterized neuropathic pain, neurophysiological and neuropathologi-
cal alterations induced by chronic chemotherapy in immunodeficient nude mice. Mice 
were treated with effective doses of cisplatin (4 mg/Kg, i.p), paclitaxel (80 mg/Kg, i.v) 
and bortezomib (0.8 mg/Kg, i.v) for a 4-6 weeks period. At the end of the 6th week 
all chemotherapy regimens determined a significant impairment of neurophysiologic 
parameters, mechanical allodynia and thermal hypo-or hyperalgesia. Light microscopy 
analysis of dorsal root ganglia (DRG) showed that bortezomib induced morphologi-
cal alterations in the sensory neurons and satellite cells as dark inclusions and clear 
vacuolation throughout the cytoplasm. Moreover, sporadic episodes of neuronal 
degeneration were evident. DRG of cisplatin-treated animals showed severe neuronal 
atrophy. Moreover bortezomib induced moderate to severe axonal degeneration of the 
myelinated fibers in the sciatic nerves. More severe changes were induced by pacli-
taxel where also areas of fibers loss were frequently observed and rare pathological 
abnormalities were present in unmyelinated fibers. Similar changes were evident in 
paclitaxel-treated mice (degeneration at different stage of severity in myelinated fib-
ers, enlargement of Schwann cells, fibers loss and dark inclusions in the unmyelinated 
fibers). These schedules demonstrated to be effective in mimicking clinical features of 
painful neuropathies and allows to combine the study of peripheral neurotoxicity of 
chemotherapy drugs to their anti-tumour activity against cancers of human origin. 
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